Contact Us: 01282 426380
KM Financial Solutions | UPDATE 4-Amgen to buy Celgene psoriasis drug Otezla for $13.4 billion
49717
post-template-default,single,single-post,postid-49717,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

UPDATE 4-Amgen to buy Celgene psoriasis drug Otezla for $13.4 billion

25 Aug UPDATE 4-Amgen to buy Celgene psoriasis drug Otezla for $13.4 billion

Posted at 19:35h in News by
0 Likes
Amgen Inc will buy Celgene
Corp’s psoriasis drug Otezla for $13.4 billion in cash,
clearing the way for Bristol-Myers Squibb to go ahead
with its $74 billion deal for Celgene by the end of the year.

No Comments

Sorry, the comment form is closed at this time.